Skip to main content
. 2020 Jul 3;21:100230. doi: 10.1016/j.jcte.2020.100230

Fig. 2.

Fig. 2

Boxplots for course of BMI levels in four cohorts of transgender men and women receiving gender affirming hormone therapy over the period of 7 years. A: transgender women who entered the cohort after on GAHT for more than 6 months (P-value = 0.064). B: transgender women who entered the cohort prior to starting GAHT (P-value = 0.004). C: transgender men who entered the cohort after on GAHT for more than 6 months (P-value = 0.739). D: transgender men who entered the cohort prior to starting GAHT (P-value = 0.790).